157 related articles for article (PubMed ID: 25926742)
61. Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non-Small Cell Lung Cancer
Naz S; Sowers A; Choudhuri R; Wissler M; Gamson J; Mathias A; Cook JA; Mitchell JB
Clin Cancer Res; 2018 Aug; 24(16):3994-4005. PubMed ID: 29716919
[No Abstract] [Full Text] [Related]
62. OTU deubiquitinase 4 is silenced and radiosensitizes non-small cell lung cancer cells via inhibiting DNA repair.
Wu Z; Qiu M; Guo Y; Zhao J; Liu Z; Wang H; Meng M; Yuan Z; Mi Z
Cancer Cell Int; 2019; 19():99. PubMed ID: 31011293
[TBL] [Abstract][Full Text] [Related]
63. [Cetuximab in combination with icotinib overcomes the acquired resistance caused by EGFR T790M mutation in non-small cell lung cancer].
Wang M; Zhang L; Zhao X; Liu J; Chen Y; Wang C
Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):651-6. PubMed ID: 25564053
[TBL] [Abstract][Full Text] [Related]
64. Epidermal growth factor receptor and DNA double strand break repair: the cell's self-defence.
Szumiel I
Cell Signal; 2006 Oct; 18(10):1537-48. PubMed ID: 16713182
[TBL] [Abstract][Full Text] [Related]
65. Lapatinib, a Dual Inhibitor of Epidermal Growth Factor Receptor (EGFR) and HER-2, Enhances Radiosensitivity in Mouse Bladder Tumor Line-2 (MBT-2) Cells In Vitro and In Vivo.
Mu Y; Sun D
Med Sci Monit; 2018 Aug; 24():5811-5819. PubMed ID: 30125265
[TBL] [Abstract][Full Text] [Related]
66. Inhibiting polo-like kinase 1 enhances radiosensitization via modulating DNA repair proteins in non-small-cell lung cancer.
Yao D; Gu P; Wang Y; Luo W; Chi H; Ge J; Qian Y
Biochem Cell Biol; 2018 Jun; 96(3):317-325. PubMed ID: 29040814
[TBL] [Abstract][Full Text] [Related]
67. Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation.
Das AK; Sato M; Story MD; Peyton M; Graves R; Redpath S; Girard L; Gazdar AF; Shay JW; Minna JD; Nirodi CS
Cancer Res; 2006 Oct; 66(19):9601-8. PubMed ID: 17018617
[TBL] [Abstract][Full Text] [Related]
68. Investigations of (99m)Tc-labeled glucarate as a SPECT radiotracer for non-small cell lung cancer (NSCLC) and potential tumor uptake mechanism.
Meng L; Xiu Y; Li Y; Xu X; Li S; Li X; Pak KY; Shi H; Cheng D
Nucl Med Biol; 2015 Jul; 42(7):608-13. PubMed ID: 25890861
[TBL] [Abstract][Full Text] [Related]
69. The radioprotector O-phospho-tyrosine stimulates DNA-repair via epidermal growth factor receptor- and DNA-dependent kinase phosphorylation.
Dittmann K; Mayer C; Wanner G; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Sep; 84(3):328-34. PubMed ID: 17714814
[TBL] [Abstract][Full Text] [Related]
70. Proton Irradiation Sensitizes Radioresistant Non-small Cell Lung Cancer Cells by Modulating Epidermal Growth Factor Receptor-mediated DNA Repair.
Park HJ; Oh JS; Chang JW; Hwang SG; Kim JS
Anticancer Res; 2016 Jan; 36(1):205-12. PubMed ID: 26722045
[TBL] [Abstract][Full Text] [Related]
71. DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression.
An J; Huang YC; Xu QZ; Zhou LJ; Shang ZF; Huang B; Wang Y; Liu XD; Wu DC; Zhou PK
BMC Mol Biol; 2010 Mar; 11():18. PubMed ID: 20205745
[TBL] [Abstract][Full Text] [Related]
72. The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport.
Dittmann K; Mayer C; Kehlbach R; Rodemann HP
Radiother Oncol; 2008 Mar; 86(3):375-82. PubMed ID: 18237807
[TBL] [Abstract][Full Text] [Related]
73. DNA double-strand break repair, DNA-PK, and DNA ligases in two human squamous carcinoma cell lines with different radiosensitivity.
Polischouk AG; Cedervall B; Ljungquist S; Flygare J; Hellgren D; Grénman R; Lewensohn R
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):191-8. PubMed ID: 9989526
[TBL] [Abstract][Full Text] [Related]
74. Intrinsic Radiosensitivity and Cellular Characterization of 27 Canine Cancer Cell Lines.
Maeda J; Froning CE; Brents CA; Rose BJ; Thamm DH; Kato TA
PLoS One; 2016; 11(6):e0156689. PubMed ID: 27257868
[TBL] [Abstract][Full Text] [Related]
75. NONO phase separation enhances DNA damage repair by accelerating nuclear EGFR-induced DNA-PK activation.
Fan XJ; Wang YL; Zhao WW; Bai SM; Ma Y; Yin XK; Feng LL; Feng WX; Wang YN; Liu Q; Hung MC; Wan XB
Am J Cancer Res; 2021; 11(6):2838-2852. PubMed ID: 34249431
[TBL] [Abstract][Full Text] [Related]
76. Nuclear EGFR is required for cisplatin resistance and DNA repair.
Hsu SC; Miller SA; Wang Y; Hung MC
Am J Transl Res; 2009 Mar; 1(3):249-58. PubMed ID: 19956435
[TBL] [Abstract][Full Text] [Related]
77. Radiosensitivity in Non-Small-Cell Lung Cancer by MMP10 through the DNA Damage Repair Pathway.
Bi Y; Cao K; Wang Y; Yang W; Ma N; Lei X; Chen Y
J Oncol; 2023; 2023():5636852. PubMed ID: 36908704
[TBL] [Abstract][Full Text] [Related]
78. Calcium channel α2δ1 subunit (CACNA2D1) enhances radioresistance in cancer stem-like cells in non-small cell lung cancer cell lines.
Sui X; Geng JH; Li YH; Zhu GY; Wang WH
Cancer Manag Res; 2018; 10():5009-5018. PubMed ID: 30464601
[TBL] [Abstract][Full Text] [Related]
79. Differences in Radiosensitivity According to EGFR Mutation Status in Non-Small Cell Lung Cancer: A Clinical and In Vitro Study.
Tanaka H; Karita M; Ueda K; Ono T; Kajima M; Manabe Y; Fujimoto K; Yuasa Y; Shiinoki T
J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38248726
[TBL] [Abstract][Full Text] [Related]
80. Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer.
Takeda M; Okamoto I; Nishimura Y; Nakagawa K
Lung Cancer (Auckl); 2011; 2():59-67. PubMed ID: 28210119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
